Antimicrobial susceptibility of Pseudomonas aeruginosa: results of a UK survey and evaluation of the British Society for Antimicrobial Chemotherapy disc susceptibility test.
暂无分享,去创建一个
D. Livermore | D. James | M. Warner | D M Livermore | C J Henwood | D James | M Warner | C. Henwood
[1] D M Livermore,et al. Quality of antimicrobial susceptibility testing in the UK: a Pseudomonas aeruginosa survey revisited. , 1999, The Journal of antimicrobial chemotherapy.
[2] N. Woodford,et al. Carbapenemases of Chryseobacterium(Flavobacterium) meningosepticum: Distribution ofblaB and Characterization of a Novel Metallo-β-Lactamase Gene, blaB3, in the Type Strain, NCTC 10016 , 2000, Antimicrobial Agents and Chemotherapy.
[3] D. Livermore. β-Lactamases of Pseudomonas aeruginosa , 1991 .
[4] I. Phillips,et al. Mechanisms of resistance to aminoglycosides in clinical isolates. , 1982, The Journal of antimicrobial chemotherapy.
[5] T. Köhler,et al. Patterns and modes of β-lactam resistance in Pseudomonas aeruginosa , 1999 .
[6] J. Williams,et al. National survey of antibiotic resistance in Pseudomonas aeruginosa. , 1984, The Journal of antimicrobial chemotherapy.
[7] D. Livermore,et al. Multicentre survey of the comparative in-vitro activity of piperacillin/tazobactam against bacteria from hospitalized patients in the British Isles. , 1993, The Journal of antimicrobial chemotherapy.
[8] D. Livermore,et al. Sensitivity testing of ciprofloxacin for Pseudomonas aeruginosa. , 1997, The Journal of antimicrobial chemotherapy.
[9] K. Bush,et al. Carbapenem-hydrolyzing beta-lactamases , 1997, Antimicrobial agents and chemotherapy.
[10] D. Livermore,et al. National survey of susceptibility to antimicrobials amongst clinical isolates of Pseudomonas aeruginosa. , 1995, The Journal of antimicrobial chemotherapy.
[11] S. Ichiyama,et al. Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems , 1996, Antimicrobial agents and chemotherapy.
[12] A. Oliver,et al. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. , 2000, Science.
[13] Y. Carmeli,et al. Emergence of Antibiotic-Resistant Pseudomonas aeruginosa: Comparison of Risks Associated with Different Antipseudomonal Agents , 1999, Antimicrobial Agents and Chemotherapy.
[14] J. Verhoef,et al. Antimicrobial Resistance in European Isolates of Pseudomonas aeruginosa , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[15] C. J. Thomson,et al. A study of the mechanisms involved in imipenem resistance in Pseudomonas aeruginosa isolates from Japan. , 1998, The Journal of antimicrobial chemotherapy.
[16] D. Livermore,et al. β-Lactamase Lability and Inducer Power of Newer β-Lactam Antibiotics in Relation to Their Activity Against β-Lactamase-Inducibility Mutants of Pseudomonas aeruginosa , 1987 .
[17] J. Andrews. BSAC standardized disc susceptibility testing method , 2001 .